211 related articles for article (PubMed ID: 2871053)
1. Infarct size reduction: a review of the clinical trials.
Campbell CA; Przyklenk K; Kloner RA
J Clin Pharmacol; 1986; 26(5):317-29. PubMed ID: 2871053
[TBL] [Abstract][Full Text] [Related]
2. Interventions that potentially limit myocardial infarct size: overview of clinical trials.
Yusuf S
Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096
[TBL] [Abstract][Full Text] [Related]
3. Efforts to limit the size of myocardial infarcts.
Rude RE; Muller JE; Braunwald E
Ann Intern Med; 1981 Dec; 95(6):736-61. PubMed ID: 6118084
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
[TBL] [Abstract][Full Text] [Related]
5. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
6. Can infarct size be limited in patients with acute myocardial infarction?
Muller JE; Braunwald E
Cardiovasc Clin; 1983; 13(1):147-61. PubMed ID: 6129059
[No Abstract] [Full Text] [Related]
7. Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
Epstein SE; Palmeri ST
Am J Cardiol; 1984 Dec; 54(10):1245-52. PubMed ID: 6150630
[TBL] [Abstract][Full Text] [Related]
8. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
9. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
Willerson JT; Buja LM
Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic therapies after myocardial infarction.
Rapaport E; Gheorghiade M
Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
[TBL] [Abstract][Full Text] [Related]
12. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
13. Combined receptor intervention and myocardial infarction.
Chamberlain DA; Vincent R
Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal coronary angioplasty during acute myocardial infarction.
Remetz MS; Cleman MW
Cardiol Clin; 1988 Feb; 6(1):139-52. PubMed ID: 2971441
[TBL] [Abstract][Full Text] [Related]
15. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy.
Willerson JT; Buja LM
Am J Cardiol; 1990 May; 65(19):35I-41I. PubMed ID: 2186610
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of ischemia in acute myocardial infarction].
Kiowski W
Schweiz Med Wochenschr; 1990 Oct; 120(42):1531-8. PubMed ID: 1978408
[TBL] [Abstract][Full Text] [Related]
17. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
Cucherat M; Bonnefoy E; Tremeau G
Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812
[TBL] [Abstract][Full Text] [Related]
18. Determinants of salvage of jeopardized myocardium after coronary thrombolysis.
Bergmann SR; Fox KA; Ludbrook PA
Cardiol Clin; 1987 Feb; 5(1):67-77. PubMed ID: 2951009
[TBL] [Abstract][Full Text] [Related]
19. Role of nitrates in acute myocardial infarction.
Flaherty JT
Am J Cardiol; 1987 Nov; 60(15):35H-38H. PubMed ID: 3120563
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
Koenig W; Löwel H; Lewis M; Hörmann A
Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
